Helen Collins – Biography
Last update: April 22, 2026Executive profile
Helen was Director and Global Lead at Gilead Sciences, and Clinical Medical Director at Amgen. Helen Collins joined Kura Oncology in 2022.
Helen Collins is currentlyChief Medical Officer at Enliven Therapeutics - View - Enliven Therapeutics org chart
Principal, National Head of Affordable Housing and Managing Director of Midlands Region at Avison Young UK - View - Avison Young UK org chart
Director at IO Biotech - View - IO Biotech org chart
Director at Kura Oncology - View - Kura Oncology org chart
Create your alert
to follow the career of Helen Collins.
Education
In 1988, Helen Collins completed a Medical Doctor at Johns Hopkins University School of Medicine.
They have also studied at Johns Hopkins University School of Medicine :
Find more alumni from Johns Hopkins University School of Medicine
More about Helen Collins
Selected links
Do you need to know more about Helen Collins? More results.
Participate
Social media
- Helen Collins on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Helen Collins
The colleagues of Helen Collins
Company Colleagues
- At Enliven Therapeutics, Helen Collins has 17 colleagues including Rick Fair (CEO & Director), Rich Heyman (Director)…
- At Avison Young UK, Helen Collins has 59 colleagues including George Roberts (President), Jo Davis (Executive Chair)…
- At IO Biotech, Helen Collins has 19 colleagues including Mai-Britt Zocca (CEO & Director), Christian Elling (Director)…
- At Kura Oncology, Helen Collins has 28 colleagues including Troy Wilson (CEO & Chairman), Thomas Malley (Director)…
Industry Colleagues
- In the Biotechnology industry, Helen Collins has 35,757 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Helen Collins.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Helen Collins.
